Selected research
Industry Growth & Trends
Global Drug Detection and Analysis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Drug Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Drug Detection and Analysis market include Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drug Detection and Analysis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug Detection and Analysis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Detection and Analysis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Detection and Analysis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug Detection and Analysis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug Detection and Analysis Market by Company
Eurofins Scientific
SGS
Labcorp
Intertek
WuXi AppTec
Charles River Laboratories
ICON pIc
IQVIA
Medpace
Syneos Health
Frontage Laboratories
Pace Analytical Services
Element Materials Technology
ALS Limited
STERIS
LGC Limited
Almac Group
Catalent
Cambrex
Alcami
Toxikon
Boston Analytical
Drug Detection and Analysis Segment by Type
Chemical Drug Testing
Biopharmaceutical Testing
Traditional Chinese Medicine Testing
Others
Drug Detection and Analysis Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Drug Regulatory Authorities
Others
Drug Detection and Analysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Detection and Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug Detection and Analysis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Drug Testing
- Biopharmaceutical Testing
- Traditional Chinese Medicine Testing
- Others
Applications
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Drug Regulatory Authorities
- Others
Companies covered
- Eurofins Scientific
- SGS
- Labcorp
- Intertek
- WuXi AppTec
- Charles River Laboratories
- ICON pIc
- IQVIA
- Medpace
- Syneos Health
- Frontage Laboratories
- Pace Analytical Services
- Element Materials Technology
- ALS Limited
- STERIS
- LGC Limited
- Almac Group
- Catalent
- Cambrex
- Alcami
- Toxikon
- Boston Analytical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug Detection and Analysis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug Detection and Analysis Market Size by Region (2021-2032)
- 1.4.1 Global Drug Detection and Analysis Market Size by Region (2021-2026)
- 1.4.2 Global Drug Detection and Analysis Market Size by Region (2027-2032)
- 1.5 Key Regions Drug Detection and Analysis Market Size (2021-2032)
- 1.5.1 North America Drug Detection and Analysis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug Detection and Analysis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug Detection and Analysis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (2021-2032)
2 Drug Detection and Analysis Market by Type
- 2.1 Type Introduction
- 2.1.1 Chemical Drug Testing
- 2.1.2 Biopharmaceutical Testing
- 2.1.3 Traditional Chinese Medicine Testing
- 2.1.4 Others
- 2.2 Global Drug Detection and Analysis Market Size by Type
- 2.2.1 Global Drug Detection and Analysis Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug Detection and Analysis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug Detection and Analysis Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug Detection and Analysis Market Size by Regions
- 2.3.1 North America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
3 Drug Detection and Analysis Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Biopharmaceutical Companies
- 3.1.3 Drug Regulatory Authorities
- 3.1.4 Others
- 3.2 Global Drug Detection and Analysis Market Size by Application
- 3.2.1 Global Drug Detection and Analysis Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug Detection and Analysis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug Detection and Analysis Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug Detection and Analysis Market Size by Regions
- 3.3.1 North America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug Detection and Analysis Industry Trends
- 4.2 Drug Detection and Analysis Industry Drivers
- 4.3 Drug Detection and Analysis Industry Opportunities and Challenges
- 4.4 Drug Detection and Analysis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug Detection and Analysis Revenue (2021-2026)
- 5.2 Global Drug Detection and Analysis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug Detection and Analysis Key Company Headquarters & Area Served
- 5.4 Global Drug Detection and Analysis Company, Product Type & Application
- 5.5 Global Drug Detection and Analysis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug Detection and Analysis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug Detection and Analysis Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug Detection and Analysis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins Scientific
- 6.1.1 Eurofins Scientific Company Information
- 6.1.2 Eurofins Scientific Business Overview
- 6.1.3 Eurofins Scientific Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins Scientific Drug Detection and Analysis Product Portfolio
- 6.1.5 Eurofins Scientific Recent Developments
- 6.2 SGS
- 6.2.1 SGS Company Information
- 6.2.2 SGS Business Overview
- 6.2.3 SGS Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 SGS Drug Detection and Analysis Product Portfolio
- 6.2.5 SGS Recent Developments
- 6.3 Labcorp
- 6.3.1 Labcorp Company Information
- 6.3.2 Labcorp Business Overview
- 6.3.3 Labcorp Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Labcorp Drug Detection and Analysis Product Portfolio
- 6.3.5 Labcorp Recent Developments
- 6.4 Intertek
- 6.4.1 Intertek Company Information
- 6.4.2 Intertek Business Overview
- 6.4.3 Intertek Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Intertek Drug Detection and Analysis Product Portfolio
- 6.4.5 Intertek Recent Developments
- 6.5 WuXi AppTec
- 6.5.1 WuXi AppTec Company Information
- 6.5.2 WuXi AppTec Business Overview
- 6.5.3 WuXi AppTec Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 WuXi AppTec Drug Detection and Analysis Product Portfolio
- 6.5.5 WuXi AppTec Recent Developments
- 6.6 Charles River Laboratories
- 6.6.1 Charles River Laboratories Company Information
- 6.6.2 Charles River Laboratories Business Overview
- 6.6.3 Charles River Laboratories Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Charles River Laboratories Drug Detection and Analysis Product Portfolio
- 6.6.5 Charles River Laboratories Recent Developments
- 6.7 ICON pIc
- 6.7.1 ICON pIc Company Information
- 6.7.2 ICON pIc Business Overview
- 6.7.3 ICON pIc Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ICON pIc Drug Detection and Analysis Product Portfolio
- 6.7.5 ICON pIc Recent Developments
- 6.8 IQVIA
- 6.8.1 IQVIA Company Information
- 6.8.2 IQVIA Business Overview
- 6.8.3 IQVIA Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 IQVIA Drug Detection and Analysis Product Portfolio
- 6.8.5 IQVIA Recent Developments
- 6.9 Medpace
- 6.9.1 Medpace Company Information
- 6.9.2 Medpace Business Overview
- 6.9.3 Medpace Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Medpace Drug Detection and Analysis Product Portfolio
- 6.9.5 Medpace Recent Developments
- 6.10 Syneos Health
- 6.10.1 Syneos Health Company Information
- 6.10.2 Syneos Health Business Overview
- 6.10.3 Syneos Health Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Syneos Health Drug Detection and Analysis Product Portfolio
- 6.10.5 Syneos Health Recent Developments
- 6.11 Frontage Laboratories
- 6.11.1 Frontage Laboratories Company Information
- 6.11.2 Frontage Laboratories Business Overview
- 6.11.3 Frontage Laboratories Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Frontage Laboratories Drug Detection and Analysis Product Portfolio
- 6.11.5 Frontage Laboratories Recent Developments
- 6.12 Pace Analytical Services
- 6.12.1 Pace Analytical Services Company Information
- 6.12.2 Pace Analytical Services Business Overview
- 6.12.3 Pace Analytical Services Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pace Analytical Services Drug Detection and Analysis Product Portfolio
- 6.12.5 Pace Analytical Services Recent Developments
- 6.13 Element Materials Technology
- 6.13.1 Element Materials Technology Company Information
- 6.13.2 Element Materials Technology Business Overview
- 6.13.3 Element Materials Technology Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Element Materials Technology Drug Detection and Analysis Product Portfolio
- 6.13.5 Element Materials Technology Recent Developments
- 6.14 ALS Limited
- 6.14.1 ALS Limited Company Information
- 6.14.2 ALS Limited Business Overview
- 6.14.3 ALS Limited Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 ALS Limited Drug Detection and Analysis Product Portfolio
- 6.14.5 ALS Limited Recent Developments
- 6.15 STERIS
- 6.15.1 STERIS Company Information
- 6.15.2 STERIS Business Overview
- 6.15.3 STERIS Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 STERIS Drug Detection and Analysis Product Portfolio
- 6.15.5 STERIS Recent Developments
- 6.16 LGC Limited
- 6.16.1 LGC Limited Company Information
- 6.16.2 LGC Limited Business Overview
- 6.16.3 LGC Limited Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 LGC Limited Drug Detection and Analysis Product Portfolio
- 6.16.5 LGC Limited Recent Developments
- 6.17 Almac Group
- 6.17.1 Almac Group Company Information
- 6.17.2 Almac Group Business Overview
- 6.17.3 Almac Group Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Almac Group Drug Detection and Analysis Product Portfolio
- 6.17.5 Almac Group Recent Developments
- 6.18 Catalent
- 6.18.1 Catalent Company Information
- 6.18.2 Catalent Business Overview
- 6.18.3 Catalent Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Catalent Drug Detection and Analysis Product Portfolio
- 6.18.5 Catalent Recent Developments
- 6.19 Cambrex
- 6.19.1 Cambrex Company Information
- 6.19.2 Cambrex Business Overview
- 6.19.3 Cambrex Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Cambrex Drug Detection and Analysis Product Portfolio
- 6.19.5 Cambrex Recent Developments
- 6.20 Alcami
- 6.20.1 Alcami Company Information
- 6.20.2 Alcami Business Overview
- 6.20.3 Alcami Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Alcami Drug Detection and Analysis Product Portfolio
- 6.20.5 Alcami Recent Developments
- 6.21 Toxikon
- 6.21.1 Toxikon Company Information
- 6.21.2 Toxikon Business Overview
- 6.21.3 Toxikon Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Toxikon Drug Detection and Analysis Product Portfolio
- 6.21.5 Toxikon Recent Developments
- 6.22 Boston Analytical
- 6.22.1 Boston Analytical Company Information
- 6.22.2 Boston Analytical Business Overview
- 6.22.3 Boston Analytical Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Boston Analytical Drug Detection and Analysis Product Portfolio
- 6.22.5 Boston Analytical Recent Developments
7 North America
- 7.1 North America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug Detection and Analysis Market Size by Country (2021-2026)
- 7.3 North America Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug Detection and Analysis Market Size by Country (2021-2026)
- 8.3 Europe Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug Detection and Analysis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug Detection and Analysis Market Size by Country (2021-2026)
- 10.3 South America Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug Detection and Analysis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst